Real-world effectiveness and safety of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma: a retrospective analysis from China - Top-Institutions - MDSpire

Real-world effectiveness and safety of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma: a retrospective analysis from China

  • By

  • Wei Jiang

  • Wei Zhong

  • Jingdi Yu

  • Yufei Tang

  • Qunyi Guo

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Shangyu People’s Hospital of Shaoxing
    Shangyu People’s Hospital of Shaoxing

    Shaoxing, Zhejiang

    Key Differentiators

    • Hematology
  • #2

    Taizhou Hospital of Zhejiang Province
    Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang

    Key Differentiators

    • Hematology
  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
  • #4

    Singapore General Hospital
    Singapore General Hospital

    Singapore, Singapore

    Key Differentiators

    • Hematology
  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Hematology

Original Source(s)

Related Content